Business
Dow Dropped Due to Swiss Drugmaker's Setback
The Dow Jones futures fell sharply due to a late-stage setback in a cardiovascular drug trial by a Swiss company. Investors are concerned about the impact on earnings and stock value.
Coverage timeline — 1 article
MarketWatch
Futures on the Dow were significantly worse than the S&P 500 because of a cardiovascular drug’s late-stage setback.
2026-09-08 08:15 UTC